Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026)
Dentsply Sirona (XRAY) posted Cash from Financing Activities of -$119.0 million for Q1 2026, down 20.2% on a QoQ basis from -$99.0 million in Q4 2025, and down 196.75% year-over-year from $123.0 million in Q1 2025.
Dentsply Sirona (XRAY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Dentsply Sirona's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$119.0 million for Q1 2026.
- Quarterly Cash from Financing Activities fell 196.75% year-over-year to -$119.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$322.0 million (down 95.15% YoY) and the FY2025 annual result came in at -$80.0 million, up 73.51% from the prior year.
- Cash from Financing Activities was -$119.0 million for Q1 2026 at Dentsply Sirona, down from -$99.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $123.0 million in Q1 2025 and bottomed at -$171.0 million in Q2 2024.
- A 5-year average of -$66.9 million and a median of -$79.0 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 1716.67% — and 2025, when it jumped 978.57%.
- Dentsply Sirona's Cash from Financing Activities stood at -$161.0 million in 2022, then advanced by 20.5% to -$128.0 million in 2023, then surged by 70.31% to -$38.0 million in 2024, then plunged by 160.53% to -$99.0 million in 2025, then decreased by 20.2% to -$119.0 million in 2026.
- Business Quant data shows XRAY's Cash from Financing Activities at -$119.0 million in Q1 2026, -$99.0 million in Q4 2025, and -$36.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Dentsply Sirona | 2.54 Bn | 2.35 Bn | 427.00 Mn | -119.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.00 Mn |
| Mar 31, 2026 | -119.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Dec 31, 2025 | -99.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Sep 30, 2025 | -36.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Jun 30, 2025 | -68.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Mar 31, 2025 | 123.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Dec 31, 2024 | -38.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Sep 30, 2024 | -79.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Dec 31, 2023 | -128.00 Mn |
| Dec 31, 2023 | -128.00 Mn |